Researchers have been racing to learn more about how this mysterious signaling molecule works to.
Despite the fact that hundreds of thousands of patients with atherosclerotic cardiovascular disease (ASCVD) are.
According to a study headed by University of Pittsburgh researchers and published in Nature Medicine,.
Research led by the National Institute for Health and Care Research (NIHR) Leicester Biomedical Research.
According to a study of more than 6.5 million people published today in the European.